Literature DB >> 25501954

Diagnose and adios: practical tips for the ongoing evaluation and care of TAC patients taking indomethacin.

Laura B Xanders1, Jessica Ailani.   

Abstract

Paroxysmal hemicrania and hemicrania continua are primary headache disorders characterized by unilateral attacks of severe pain around the orbit with associated autonomic features. They are unique in their absolute response to indomethacin. Diagnosis is made when patients with suspected paroxysmal hemicrania or hemicrania continua have the resolution of headache with therapeutic doses of indomethacin. Once diagnosis is made, limited data exists on the ongoing management of these patients. For patients who do not tolerate indomethacin, or wish to come off medication, there remain few options. This article will discuss the diagnosis of paroxysmal hemicrania and hemicrania continua and the ongoing management of patients on indomethacin, as well as options for patients who do not tolerate or need to come off indomethacin.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25501954     DOI: 10.1007/s11916-014-0470-z

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  31 in total

1.  Episodic paroxysmal hemicrania responsive to calcium channel blockers.

Authors:  F Coria; L E Claveria; F J Jimenez-Jimenez; E V de Seijas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-02       Impact factor: 10.154

Review 2.  Chronic paroxysmal hemicrania (CPH): a review of the clinical manifestations.

Authors:  F Antonaci; O Sjaastad
Journal:  Headache       Date:  1989-11       Impact factor: 5.887

Review 3.  Diagnosis and management of chronic daily headache.

Authors:  Ivan Garza; Todd J Schwedt
Journal:  Semin Neurol       Date:  2010-03-29       Impact factor: 3.420

Review 4.  "Hemicrania continua": a clinical review.

Authors:  C Bordini; F Antonaci; L J Stovner; H Schrader; O Sjaastad
Journal:  Headache       Date:  1991-01       Impact factor: 5.887

Review 5.  Trigeminal autonomic cephalalgias: current and future treatments.

Authors:  Anna S Cohen; Manjit S Matharu; Peter J Goadsby
Journal:  Headache       Date:  2007-06       Impact factor: 5.887

6.  "Hemicrania continua": the first bilateral case?

Authors:  F Pasquier; D Leys; H Petit
Journal:  Cephalalgia       Date:  1987-09       Impact factor: 6.292

7.  "Hemicrania continua": another headache absolutely responsive to indomethacin.

Authors:  O Sjaastad; E L Spierings
Journal:  Cephalalgia       Date:  1984-03       Impact factor: 6.292

Review 8.  Trigeminal autonomic cephalgias and variants: clinical profile in Indian patients.

Authors:  A Chakravarty; A Mukherjee; D Roy
Journal:  Cephalalgia       Date:  2004-10       Impact factor: 6.292

9.  Adolescent chronic paroxysmal hemicrania responsive to verapamil monotherapy.

Authors:  N Shabbir; G McAbee
Journal:  Headache       Date:  1994-04       Impact factor: 5.887

10.  Hemicrania continua responsive to botulinum toxin type a: a case report.

Authors:  Modar Khalil; Fayyaz Ahmed
Journal:  Headache       Date:  2013-03-27       Impact factor: 5.887

View more
  1 in total

Review 1.  Paroxysmal Hemicrania.

Authors:  Chinar Osman; Anish Bahra
Journal:  Ann Indian Acad Neurol       Date:  2018-04       Impact factor: 1.383

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.